Freestone Grove Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131M Sell
517,230
-37,143
-7% -$8.66M 0.84% 11
2026
Q1
$136M Buy
554,373
+407,303
+277% +$94.9M 0.96% 4
2025
Q4
$30.4M Buy
147,070
+141,687
+2,632% +$28M 0.22% 152
2025
Q3
$998K Buy
+5,383
New +$922K 0.01% 440
2025
Q1
– Sell
-14,813
Closed -$2.14M – 693
2024
Q4
$2.14M Buy
+14,813
New +$2.3M 0.03% 261

Other funds holding JNJ

Freestone Grove Partners's JNJ Position: Q2 2026 in Review

Freestone Grove Partners reduced its Johnson & Johnson (JNJ) stake by 6.7% in Q2 2026, selling an estimated $8.66M and leaving 517,230 shares worth $131M. The position accounts for 0.84% of the portfolio, ranked #11.

Freestone Grove Partners first reported a position in JNJ in Q4 2024 and has held it in 5 quarters since. The position peaked at $136M in Q1 2026. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Freestone Grove Partners held 517,230 shares of Johnson & Johnson worth $131M as of Q2 2026.
  • Freestone Grove Partners sold 37,143 Johnson & Johnson shares in Q2 2026, an estimated $8.66M.
  • Johnson & Johnson made up 0.84% of Freestone Grove Partners's portfolio in Q2 2026, its #11 holding.
  • Freestone Grove Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's Johnson & Johnson position peaked at $136M in Q1 2026.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.